Despite annual losses, Arrhythmia Research Technologies of Fitchburg posted revenue gains in the first quarter of 2013, according to an earnings statement.
Total consolidated revenue for the quarter that ended March 31 was $5.6 million, up from $5.1 million in the fourth quarter of 2012. Year-over-year, revenue declined 3.2 percent for Arrhythmia, from $5.8 million in the quarter ended March 31, 2012, but quarterly losses decreased sharply, from $435,919 in 2012 to $5,671 in 2013.
Salvatore Emma Jr., who assumed the role of president and CEO in April, said sales increases in the company’s subsidiary, Micron Products, and increased sales of orthopedic implant products, contributed to quarterly gains, though revenue from Micron’s sensors decreased $1.1 million compared to last year.
